Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Journal of the American College of Cardiology · 131 citations
https://doi.org/10.1016/j.jacc.2021.04.102
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
442
Citations
5
h-index
5
i10-index
Ramprasad Dandillaya is an academic researcher. The author has contributed to research in topics: Hormonal Regulation and Hypertension & Diet and metabolism studies & Lipoproteins and Cardiovascular Health. The author has an h-index of 5, co-authored 8 publications.
https://doi.org/10.1016/j.jacc.2021.04.102
https://doi.org/10.1161/circulationaha.124.071269
Click to start Chat